Pharmaceutical Engineering Sciences
Experts in pharmaceutical formulation development
The Centre for Pharmaceutical Engineering Science (CPES) is an interdisciplinary research and industrial collaboration centre, which has expertise across the pharmaceutical sciences, chemistry and polymer engineering disciplines with an excellent reputation for contract research and working with industry.
CPES academic research is focused on developing an in-depth fundamental understanding of the influencing factors on both product and process development in the pharmaceutical and related industries, including use of Process Analytical Technology (PAT) and Quality by Design (QbD) approaches to pharmaceutical product development and process optimisation.
CPES offers expertise and contract research services in the areas of preformulation analysis, pharmaceutical formulation development, poorly soluble drugs, amorphous forms, melt technologies, crystal engineering and cocrystals, particle size reduction technologies and novel polymorphic transitions.
A key focus of the research undertaken at CPES is the development of innovative formulation technologies in the area of pharmaceutical and healthcare formulation.
Innovators in drug delivery
Our pharmaceutical formulation development services includes know-how over a range of enabling technologies focused on solubility enhancement of poorly soluble actives including melt technologies, spray and freeze drying and nanosuspensions covering a range of drug delivery systems including transdermal, parenteral, inhaled and more conventional oral formulations.
The Centre for Pharmaceutical Engineering Science is located across the University’s city campus having laboratories in the Norcroft Building and the Polymer IRC providing a wide range of excellent research facilities and equipment enabling our scientists to design of novel formulation technologies for the development of enhanced pharmaceutical and related products.
Commercialisation of novel technologies
A key focus of the research undertaken at CPES is the development of novel technologies in the general area of pharmaceutical and healthcare formulation. The centre has an excellent record of developing intellectual property for commercialisation through collaboration with appropriate industry partners.
We are currently seeking commercial partners for the following innovative technologies:
- Non-hygroscopic effervescent solid dosage formulations
- Novel abuse resistant systems for opiate drug delivery
- Solvent free process for manufacture of co-crystals
- Stable novel polymorphs of pharmaceutical actives
CPES offers a number of opportunities for students to engage in post-graduate studies. We welcome applications from students to undertake MPhil, PhD and MSc studies in the following areas:
- pharmaceutical materials
- drug delivery systems
- novel process development
- reactive extrusion
- material characterisation
- Process Analytical Technology (PAT)
MSc in Pharmaceutical Technology
The interdisciplinary postgraduate MSc programme in Pharmaceutical Technology has been developed to meet the current and future requirements of the global pharmaceutical industry. This unique course will provide students with a wider exposure to and understanding of pharmaceutical technologies, delivery systems and process analytics.
How to apply
If you would like to undertake a MPhil or PhD research programme with The Centre for Pharmaceutical Engineering Science please identify your area of interest by visiting the PhD in Pharmacy and Medical Science pages and viewing the current PhD programmes available under Medicines Development and Pharmaceutcial Sciences (MDPS) pages.
We are also able to offer practical lab based training for Undergraduate and Graduate students looking to enhance their laboratory skills and techniques. Please contact us if you would like to undertake a placement at The Centre for Pharmaceutical Engineering Science
CPES wins second ICURe Market Validation funding for FastAct technology
The team at CPES has recently developed “FastAct” Technology which is a ground breaking invention related to enhanced bioavailability of drugs. FastAct is targeted to address poorly soluble actives in the pharmaceutical, nutraceutical and agrochemical sectors.
CPES wins ICURe Market Validation funding for SelfGel technology
The team at CPES has recently developed “SelfGel” Technology which is a new bioadhesive gelling system. The novel technology was designed to address the challenges faced by current gel based formulations when used in topical applications
The nutritious gains of in-house granulation
Principle Healthcare worked with the Centre for Pharmaceutical Engineering Sciences to research the option of developing in-house granulation technology for their nutritional supplements.
Decade long relationship enhanced by knowledge transfer partnerships
The Centre for Pharmaceutical Engineering Sciences has secured its second Knowledge Transfer Partnership with Natures Laboratory to support their latest innovation goals using the healing properties of propolis. Natures Laboratory, a natural medicine manufacturer, have been working with CPES since 2007.
Meet the team
General Enquiries email@example.com
Professor Anant Paradkar - Director
Dr Jason Jones - Business Development
T: +44-1274- 236193
Centre for Pharmaceutcial Engineering Science
University of Bradford